Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Novartis India Q3 net profit dips 31 percent to Rs 12.87 crore

      Novartis India Q3 net profit dips 31 percent to Rs 12.87 crore

      Garima5 Feb 2019 9:15 AM IST
      The company had posted a net profit of Rs 18.74 crore for the corresponding period of the previous fiscal, Novartis India said in a filing to BSE.New...
      Unichem Labs standalone net profit declines 99.83 percent in Q3

      Unichem Labs standalone net profit declines 99.83 percent in Q3

      Garima4 Feb 2019 9:40 AM IST
      Net Sales at Rs 244.76 crore in December 2018 up 53.82% from Rs. 159.12 crore in December 2017.Mumbai: Mumbai based Unichem Laboratories Ltd. recently...
      Medlife acquires Mumbai based digital healthcare platform

      Medlife acquires Mumbai based digital healthcare platform

      Garima3 Feb 2019 9:15 AM IST
      Medlife founder and Chief Executive Officer Tushar Kumar said: "The acquisition has come at an opportune time for both the companies. While MedLabz...
      InvAscent-led India Life Sciences Fund raises Rs 25 crore for its New Fund

      InvAscent-led India Life Sciences Fund raises Rs 25 crore for its New Fund

      Garima2 Feb 2019 4:16 PM IST
      InvAscent, famed for its early-stage backing of Gland Pharma and Health Care Global through the first fund Evolvence India Life Sciences Fund, will...
      Emami acquires German brand Creme 21 for Rs 100 crore

      Emami acquires German brand Creme 21 for Rs 100 crore

      Garima2 Feb 2019 9:45 AM IST
      Creme 21, which has major business in the Middle East and other focus markets, has been acquired at less than 1.5 times of its sales, said Emami in a...
      Roche, AC Immune drop Alzheimer drug trials after setback

      Roche, AC Immune drop Alzheimer drug trials after setback

      Garima2 Feb 2019 9:15 AM IST
      The announcement from Roche and its Swiss-based partner AC Immune came after an interim analysis indicated it was unlikely to be effective, the Swiss...
      Medtronic to acquire EPIX Therapeutics, expanding its cardiac ablation portfolio

      Medtronic to acquire EPIX Therapeutics, expanding its cardiac ablation portfolio

      Garima2 Feb 2019 9:05 AM IST
      When completed, the EPIX acquisition will expand the Medtronic cardiac ablation portfolio to offer physicians a comprehensive suite of tools to treat...
      Torrent Pharma Q3 profit jumps over four fold to Rs 246 crore

      Torrent Pharma Q3 profit jumps over four fold to Rs 246 crore

      Garima31 Jan 2019 10:35 AM IST
      Torrent Pharma had posted a net profit of Rs 58 crore in the corresponding period of 2017-18, the company said in a BSE filing.Ahmedabad: Drug firm...
      Lambda Therapeutic acquires US based Novum Pharmaceutical Research Services

      Lambda Therapeutic acquires US based Novum Pharmaceutical Research Services

      Garima31 Jan 2019 9:30 AM IST
      "Combining with Lambda creates an opportunity for Novum and our clients to have a broader capability across a global footprint to accommodate the...
      Novartis sees 2019 growth as it sheds eyecare unit, narrows focus

      Novartis sees 2019 growth as it sheds eyecare unit, narrows focus

      Garima30 Jan 2019 9:00 AM IST
      Novartis said sales of its Entresto heart failure medicine accelerated along with revenue from its psoriasis-and-arthritis blockbuster...
      Teva Pharma receives US FDA approval for generic Sabril

      Teva Pharma receives US FDA approval for generic Sabril

      Garima20 Jan 2019 9:30 AM IST
      Teva’s generic Sabril(vigabatrin) tablets are part of a single shared-system Risk Evaluation and Mitigation Strategy (REMS) program.U.S: The U.S. Food...
      More trouble for Sun Pharma: Tumbles after fresh allegations by whistleblower

      More trouble for Sun Pharma: Tumbles after fresh allegations by whistleblower

      Garima18 Jan 2019 1:52 PM IST
      A whistleblower had approached SEBI late last year with a document alleging various irregularities by Sun Pharma, its promoter Dilip Shanghvi and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok